This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
G5Z Overzicht aandelen
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Neovasc Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | CA$27.00 |
| 52 Week Hoogtepunt | CA$28.00 |
| 52 Week Laag | CA$4.50 |
| Bèta | 1.98 |
| 11 maand verandering | -0.74% |
| 3 maanden verandering | 45.16% |
| 1 Jaar Verandering | 208.57% |
| 33 jaar verandering | -50.00% |
| 5 jaar verandering | -96.82% |
| Verandering sinds IPO | -99.55% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| G5Z | DE Medical Equipment | DE Markt | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.1% |
| 1Y | 208.6% | 10.5% | 18.9% |
Rendement versus industrie: G5Z exceeded the German Medical Equipment industry which returned -3.4% over the past year.
Rendement versus markt: G5Z exceeded the German Market which returned -7% over the past year.
Prijsvolatiliteit
| G5Z volatility | |
|---|---|
| G5Z Average Weekly Movement | 9.0% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: G5Z's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: G5Z's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2000 | 60 | Fred Colen | neovasc.com |
Neovasc Inc. Samenvatting
| G5Z fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €74.97m |
| Inkomsten(TTM) | -€37.50m |
| Inkomsten(TTM) | €3.46m |
21.6x
P/S-verhouding-2.0x
Koers/WinstverhoudingIs G5Z overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| G5Z resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$3.81m |
| Kosten van inkomsten | US$5.07m |
| Brutowinst | -US$1.27m |
| Overige uitgaven | US$39.93m |
| Inkomsten | -US$41.20m |
Laatst gerapporteerde inkomsten
Dec 31, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -14.93 |
| Brutomarge | -33.37% |
| Nettowinstmarge | -1,082.90% |
| Schuld/Eigen Vermogen Verhouding | 79.8% |
Hoe presteerde G5Z op de lange termijn?
Bekijk historische prestaties en vergelijking